pipette
ENEnglish

Mesaconate-Based Polyester Nanoparticles Reveal How Metabolite Isomerism Shapes Polymer Behavior, Macrophage Reprogramming, and Systemic Immunomodulation

M. M. Rana, A. L. Cottingham, S. Kolhatkar, F. Xu, A. H. Najafabadi, R. M. Pearson

Preprint

En palabras de los autores

Metabolite-based polymer nanoparticles can transform endogenous immunometabolites into intrinsically bioactive materials, yet most platforms have focused on itaconate or soluble metabolite analogs. Mesaconate is a downstream itaconate-derived immunometabolite with distinct metabolic activity, but its potential as an engineerable material building block remains largely unexplored. Here, mesaconic acid was used as a monomer to construct a degradable, cargo-free polyester nanoparticle platform. Poly(itaconate-co-decanediol) (pITA) and poly(mesaconate-co-decanediol) (pMSA) were synthesized using 1,10-decanediol and formulated into nanoparticles. Varying pMSA synthesis conditions generated distinct molecular-weight development, thermal organization, and degradation-associated behavior. Despite comparable particle size, surface charge, and morphology, pITA- and pMSA-derived nanoparticles produced activation-state-dependent macrophage immunomodulation. Under inflammatory stimulation, both nanoparticles modulated activation-associated surface molecules, whereas their transcriptomic responses diverged markedly. pITA-NPs preferentially engaged redox-, metabolic-, and cellular stress-associated programs, while pMSA-NPs exhibited a distinct lysosome-associated, inflammatory, and remodeling transcriptional profile and remained distinguishable from soluble 4-octyl itaconate. In LPS-induced endotoxemia, pMSA-NP treatment broadly modulated systemic cytokine responses, including a pronounced reduction in circulating IL-6, and improved seven-day survival relative to vehicle control. Together, these findings establish mesaconate as a synthesis-tunable polymeric immunometabolite and highlight metabolite-isomer identity and nanoparticle material state as complementary design parameters for cargo-free immunometabolic biomaterials.

Resultado principalEl resumen no menciona limitaciones.

Apareció: sábado, 24 de octubre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.22.760948